INTRODUCTION {#SEC1}
============

In mature B-cells, a major 3΄ *cis*-regulatory super-enhancer controls accessibility of immunoglobulin heavy chain (IgH) constant (*C*) genes to transcription and to IgH changes initiated by activation-induced deaminase (AID) ([@B1]--[@B3]). In the mouse, this 3΄regulatory region (*3'RR*) is made up of a cluster of four core enhancers: *hs3a, hs1,2, hs3b* and *hs4*. It barely influences *V(D)J* recombination in B-cell progenitors, except for paradoxically silencing early transcription in pro-B-cells, and barely affects basal pVH transcription in resting B-cells ([@B4],[@B5]). By contrast in plasma cells, the 3'RR strongly contributes to increased IgH transcription which physiologically marks the plasma cell stage ([@B6]). The 3'RR is also the master *cis*-regulatory region controlling conventional class switch recombination (CSR), ([@B7],[@B8]) locus suicide recombination (LSR) ([@B9]) and somatic hypermutation (SHM) ([@B10]) by modulating germline transcription of C genes in activated B-cells, chromatin remodeling of switch (S) regions, AID activity on targeted sequences, and also probably the synapsis between broken S regions which terminates CSR ([@B1],[@B11]). In addition, to being bound by specific transcription factors, 3'RR core enhancers are transcribed into eRNA ([@B9]), and regulated in their function by a distantly transcribed long non-coding RNA (lncRNA CSR) ([@B3]).

In all mammalians studied, the upstream 3'RR enhancers are embedded within a long and uniquely palindromic DNA region, with the last enhancer (*hs4*) lying outside and downstream of this palindrome ([@B1],[@B12]); for example in the mouse, the *hs3a, hs1,2* and *hs3b* core elements are found within a ∼25-kb dyad symmetry, with *hs1,2* at the center, flanked by inverted repeated intervening sequences (*IRIS*) and bound by inverted copies of the *hs3a/hs3b* enhancers (Figure [1A](#F1){ref-type="fig"}). In humans, the *3'RR* is duplicated and each 3'RR is composed of only three core enhancers (*hs3, hs1.2* and *hs4*) with *hs1,2* also flanked by *IRIS*. Despite the modest activity of each of the *3'RR* core enhancers *in vitro*, they altogether build a synergistic and potent super-enhancer notably efficient in transgenes, especially when a palindromic architecture is preserved ([@B13]). *IRIS* lack DNase1 hypersensitivity and obvious sites for transcription factors and are mostly made up of non-coding repetitive DNA. Some of these 'like switch' repeats resemble S regions and likely promote *IgH* deletion events during LSR ([@B9]). Although highly divergent in different species, *IRIS* sequences always stand as inverted copies on both sides of *hs1,2*, thus preserving 3'RR symmetry and strongly suggesting that their architectural role might be required for IgH expression. We recently deleted the upstream side of the palindrome (the 10 kb-long 5΄ IRIS) in the endogenous locus in Δ*IRIS* knock-out mice where all 3'RR core enhancers were preserved and the downstream copy of the *IRIS* remained unaltered ([@B14]). This affected SHM and to a lesser extent CSR. It was, however, questionable whether this phenotype resulted from the loss of an unknown *cis*-acting sequence included in the 5'IRIS, from the decreased distance between *hs3a* and *hs1,2*, or from loss of the 3'RR symmetry. 3'RR activity is also often considered as simply the sum of all core enhancer activities, and combinations of all 3΄ core enhancers are thus widely used as 3'RR models in transgenes ([@B15]--[@B19]). It has also recently been observed in the CH12 B-cell line, that replacement of the 28 kb-long 3'RR with a simple combination of all four core enhancers preserved or even increased *IgH* locus accessibility to *Cα* CSR ([@B20]). Since transgenes are susceptible to random insertion effects and since immortalized B-cell lines such as CH12 might be frozen with regards to chromatin marks and accessibility, we found it important to check the real effect of 3'RR replacement in the context of the endogenous *IgH* locus of primary B-cells. Compared with the recent *ΔIRIS* mouse lacking only the 5΄ IRIS, the herein reported 'core 3'RR' (*c3'RR*) mouse model completely lacks 3'RR packaging DNA. Interestingly, this complete elimination of packaging DNA around core enhancers strongly affects the main activities of the 3'RR, notably with regards to IgH expression in plasma cells, SHM and class switching. It, however, appears very similar to the phenotype of ΔIRIS mice, and thus further indicates that the 3'RR IRIS are only active when present in two copies, with a role that differs from that of a core enhancer, and is solely architectural: providing the palindromic framework that ensures optimal function of 3'RR core enhancers.

![Genomic organization of the c3'RR locus and 3'RR mutant mice. (**A**) Murine *IgH* locus (not to scale); Ig gene segments are indicated; arrows represent the palindromic inverted repeats (*top*) (*complete sequence of the 3'RR is provided in* ([@B12]) *repetitive elements are further described in* ([@B9])). Targeting vector; arrow heads represent CRISPR/cas 9 primers (*middle*). Successfully targeted *c3'RR* allele (*bottom*). (**B**) 3'RR mutant mice used in this study. The *Δ3'RR* deletion eliminates the four enhancers and the palindromic region. The *ΔIRIS* locus carries an inverted *hs3a* enhancer and lacks the intervening sequences between *hs3a* and *hs1,2*.](gkx203fig1){#F1}

MATERIALS AND METHODS {#SEC2}
=====================

Mice {#SEC2-1}
----

One hundred twenty-nine *wt* mice (from Charles River Laboratories, France) *Δ3'RR* and *c3'RR* mice (in a 129 background) were used. Our study was approved by the local ethics committee review board (Comité Régional d'Ethique sur l'Expérimentation Animale du Limousin, Limoges, France).

Vector construction and embryonic stem cell screening {#SEC2-2}
-----------------------------------------------------

The vector used for homologous recombination assembled a previously described 3΄ homology arm (located 3.5 kb downstream of hs4) ([@B8]) followed by the thymidine kinase (*Tk*) gene, and a 5΄ arm homologous to the region upstream of *hs3a* (amplified using primers listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). A *floxed* neomycin resistance gene (*neo*^R^) together with a synthetic 2.1 kb *c3'RR* cassette were inserted in between both arms, replacing the entire 3'RR. Two CRISPR vectors were created using the pX330 vector (Addgene, Cambridge, USA), for production of two guide RNAs able to target Cas9 recombinase at both ends of the desired 3'RR deletion. The various PCR primers and CRISPR sequences used are reported in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

Cells of the embryonic stem (ES) cell line CK35 were transfected with 8μg of linearized targeting vector and 0.5 μg of each CRISPR/cas9 vector by electroporation and selected using 300 μg /ml geneticin and 2 μg/ml gancyclovir.

Immunization {#SEC2-3}
------------

For immunization experiments, groups of 8-week-old mice (\>5 mice per genotype) were immunized by intraperitoneal injection of 200 μl SRBC and analyzed 8 after days.

Cell culture {#SEC2-4}
------------

Splenocytes were collected, red blood cells were lysed and cells were CD43-depleted using CD43 microbeads (Miltenyi Biotec). Spleen B lymphocytes were cultured for 5 days in RPMI containing 10% FCS with either LPS (20 μg/ml) + IL4 (40 ng/ml) (Peprotech), or LPS (20 μg/ml) + IFNγ (2 ng/ml) (RD systems) or LPS (20 μg/ml) + TGFβ (2 ng/ml) (RD systems). Supernatants were recovered at day 4 and stored at --20°C until used. Culture samples were harvested daily for RNA extraction.

CSR analysis {#SEC2-5}
------------

At day 4, *in vitro* activated splenic B-cells were incubated with anti-B220-BV510 (clone RA3-6B2, Biolegend), anti-IgG~1~-PE (clone A85-1, BD Pharmingen), anti-IgG~3~-FITC (clone R40-82, Beckton Dickinson) antibodies and analysed on a BD Pharmingen Fortessa LSR2 using BD FACSDiva software (BD Biosciences, San Jose, CA, USA).

ELISA {#SEC2-6}
-----

ELISAs for IgM, IgG~1~, IgG~3~, IgG~2a~, IgG~2b~ and IgA were performed on sera and *in vitro* stimulated B-cell supernatants from *Δ3'RR, c3'RR* and *wt* mice, as previously described ([@B8]).

Real time quantitative PCR {#SEC2-7}
--------------------------

Four day *in vitro* stimulated splenocytes (LPS + appropriate cytokines) were harvested and RNA was extracted to evaluate *I~x~-C~x~* germline transcripts (GLT). The kinetics of *I~μ~-C~x~* post switch transcription (PST) was followed daily. RNA and cDNA were prepared using standard techniques. Quantitative PCR was performed using SYBR^®^ Green (Takara). PCR primers used for determination of *I~x~-C~x~* and *Iμ-C~x~* transcripts are reported in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

Flow cytometry and cell sorting {#SEC2-8}
-------------------------------

Cell suspensions from Peyer\'s patches were labeled with anti-B220-APC- (Clone RA3-6B2, Biolegend), GL7-PE- (BD) conjugated antibodies. Sorting of B220^+^/GL7^+^ cells was performed on a FACS ARIA 3 (BD Biosciences).

SHM analysis {#SEC2-9}
------------

SHM analysis was performed as described ([@B10]) in the *J~H~4* intron, *Jk5* intron and *Sμ* region from sorted B220+/GL7+ cells from Peyer\'s patches. PCR products (100 ng) were fragmented using the Ion Shear Plus Reagents kit (Life Technologies), then barcodes and adaptors were ligated using Ion Xpress Plus Fragment (Life Technologies). Fragments around 200 pb were selected using 2% E-Gel size select (Life Technologies) and sequenced on an Ion Proton™ System. Raw fastq files were generated using Ion Torrent Suite (adapter- and barcode-trimmed) and mapped to the reference sequences using BWA-MEM (Li, 2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. *arXiv:*[*1303.3997*](http://arxiv.org/abs/1303.3997)*\[q-bio\]*. Position-wise base counts were performed with IGVtools ([@B21]) and resulting wig files were processed to call somatic mutations along the reference sequence with *ad hoc* Python scripts (available on request). Sequences were deposited on the EMBL EBI ENA website, <http://www.ebi.ac.uk/ena>, under accession number: PRJEB19507.

Statistical analysis {#SEC2-10}
--------------------

Statistical tests were performed using GraphPad Prism (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001).

RESULTS {#SEC3}
=======

Generation of c3'RR mice {#SEC3-1}
------------------------

We generated a mouse model with an *IgH* locus carrying a miniaturized 'core-3'RR' (*c3'RR*). Our gene-targeting strategy replaced the entire *3'RR* region (i.e. 30.3 kb) with the *c3'RR* (2.1 kb), which encompassed only the four core enhancers (*hs3a, hs1.2, hs3a* and *hs4*) (Figure [1A](#F1){ref-type="fig"}). To optimize gene targeting, we used CRISPR/cas 9 in order to generate double-strand breaks at both ends of the 3'RR and initiate recombination. The targeting vector was co-transfected with CRISPR/cas9 vectors in CK35 ES cells. We obtained three positive clones out of 15 tested. After germline transmission, mice were bred with *cre* expressing mice to delete the Neo^R^ cassette. In this study, *c3'RR* mice were compared to *Δ3'RR* ([@B10]) and *ΔIRIS* mice ([@B14]) (Figure [1B](#F1){ref-type="fig"}).

B-cell development {#SEC3-2}
------------------

To study B-cell development in *c3'RR* mice, we generated heterozygous *c3'RR^a^/wt^b^* mice by crossing homozygous *c3'RR^a^/c3'RR^a^* (*IgH^a^* locus from the SV129 strain) mice with C57BL/6 mice (*wt*^b^*/wt*^b^). This allowed us to study the effect of the mutation by comparison with a *wt* IgH locus in the same mouse and in the conditions of an internal competition between cells expressing either the *wt* 'b' allele or the knocked-out 'a' allotype IgH locus. B-cell development was barely affected in those B-cells expressing a rearranged *c3'RR* allele, although these IgM^a^ cells were slightly less abundant than in *wt*^a^*/wt*^b^ mice ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). Analysis of *c3'RR*^a^/*wt*^b^ (*vs w*t^a^/*wt*^b^) splenic B-cells similarly showed a slightly decreased *a/b* ratio among transitional (B220^+^ AA4.1^+^), follicular (B220^+^ CD21^low^ CD23^high^) and marginal zone (B220^+^ CD21^high^ CD23^low^) B-cells expressing either the *a* or *b* allotype. ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}).

3'RR core enhancers are sufficient to induce CSR, but with a partial defect {#SEC3-3}
---------------------------------------------------------------------------

We explored Ig production *in vitro* and *in vivo* upon extracting 3'RR core enhancers from their packaging DNA. When first examining secreted Ig levels and plasma accumulation *in vivo* (Figure [2A](#F2){ref-type="fig"}), we observed that Ig classes with short-half-lives and notably IgM and IgA were present at lower levels than in *wt* animals, in contrast with roughly normal amounts of those IgG classes with long half-lives, IgG~1~ and IgG~3~ (which can accumulate, since they are most efficiently recycled after binding to the FcRn receptor) ([@B22],[@B23]). Ig steady state plasma levels indeed integrate the rates of both production and catabolism, the latter being decreased in conditions of lowered Ig production and then notably resulting for IgG~1~, in a 3-fold increased half-life ([@B22]). It has accordingly been observed, by checking *in vitro* cultures, that in several cases of Ig production defects, that *in vivo* serum levels can be apparently preserved even when an Ig production defect is clearly present ([@B8]).

![In the absence of packaging DNA, core 3'RR enhancers partially support Ig secretion. (**A**) ELISA analysis of IgM, IgG~1~, IgG~2a~, IgG~2b~, IgG~3~ and IgA in plasma from *Δ3'RR, c3'RR* and *wt* mice. (**B**) ELISA analysis of IgM, IgG~1~, IgG~2a~, IgG~2b~, IgG~3~ and IgA in supernatants from LPS ± IL-4, INFγ and TGFβ stimulated splenocytes from *Δ3'RR, c3'RR* and *wt* mice. Mean ± SEM of two independent experiments with at least three mice and Mann Whitney test for significance.](gkx203fig2){#F2}

We next quantified Ig levels in conditions more directly reflecting Ig production, in supernatants of B-cells activated *in vitro* by LPS and appropriate cytokines. We compared *c3'RR* homozygous cells with either *wt* or homozygous *Δ3'RR* cells known to carry a strong defect in *in vitro* Ig secretion ([@B6]). An intermediate, but significant secretion defect was observed for *c3'RR* cells, affecting all IgG classes except IgG~1~, while for IgA and IgM, the trend towards a decrease was not significant (Figure [2B](#F2){ref-type="fig"}).

To better assess *in vivo* Ig production compared to lymphocyte counts, and the role of the 3'RR palindromic shell during immune activation, we quantified the boost in serum IgM and IgG~1~ after SRBC immunization in *wt* compared to homozygous 3'RR mutant mice. In pre-immune mice, normal counts of IgM+ lymphocytes contrasted with less serum IgM at the basal state in *c3'RR* and *Δ3'RR* mice; this difference persisted after SRBC activation (although serum IgM levels then increased in all animals, either *wt, c3'RR* or *Δ3'RR*) (Figure [3](#F3){ref-type="fig"}, top panel). To further evaluate the partial independence of IgG~1~ from the *c3'RR* mutation, we measured *in vivo* class-switched IgG1+ lymphocytes, which were normal in *c3'RR* mice at the basal state (Figure [3](#F3){ref-type="fig"}, bottom panel). The serum IgG1 level was also normal at the basal state, in conditions where accumulation and decreased IgG catabolism are known to occur in mice producing low amounts of IgG ([@B22]). By contrast, serum IgG~1~ was boosted in animals stimulated by SRBC injection, and then remained at a level significantly lower than in *wt* mice, this dynamic production of Ig being more sensitive to an Ig production defect (Figure [3](#F3){ref-type="fig"}, bottom panel, right).

![*In vivo* immune stimulation in the absence of 3'RR packaging DNA. FACS analysis of IgM and IgG~1~ positive cells at basal state (*left panel*) and ELISA of IgM (*top*) and IgG~1~ (*bottom*) in plasma from *Δ3'RR, c3'RR* and *wt* mice before (NI) and after SRBC immunization (*right panel*). Mean ± SEM of two independent experiments with three mice each and Mann--Whitney test for significance.](gkx203fig3){#F3}

Independently of Ig secretion, CSR can be measured more directly *in vitro* by following the change in BCR expression. To determine the impact of 3'RR miniaturization on CSR, we evaluated class switching to the various BCR isotypes after specific *in vitro* stimulation. Homozygous *c3'RR/c3'RR* cells were compared with either *wt* or homozygous *Δ3'RR* cells carrying a complete 3'RR deletion. Flow cytometry evaluated surface expression of class-switched isotypes on activated splenic B-cells from *wt, c3'RR* and *Δ3'RR* mice. As previously described ([@B6]), CSR in control *Δ3'RR* cells stimulated for 4 days, was barely detectable for all classes except for IgG~1~ (with some IgG~1-~producing cells still detectable). Although milder, a CSR phenotype reminiscent of the latter also appeared in *c3'RR* mice: class-switched IgG3 cells decreased to a level intermediate between that observed in *Δ3'RR* and *wt* mice ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}), while IgG1^+^ cells were not affected. In agreement with cell cytometry, Q-PCR in *c3'RR* cells revealed an intermediate decrease in post-switch transcripts (PST), less significant than for the *Δ3'RR* cells and diversely affecting PST from Cγ2b (down to the same low levels as in *Δ3'RR* B-cells), Cα, and to a lesser extent Cγ3, Cγ2a and Cγ1 PST which tended to be lower but did not show a significantly lower level in these experiments (Figure [4A](#F4){ref-type="fig"}).

![In the absence of packaging DNA, core 3'RR enhancers partially support IgH CSR. (**A**) Post switching transcripts in B splenocytes from *Δ3'RR, c3'RR* and *wt* mice. (**B**) Germline transcripts in B splenocytes from *Δ3'RR, c3'RR* and *wt* mice. Cells were stimulated with LPS ± IL-4, INFγ and TGFβ for 4 days. *Iγ~1~-C~γ1~, Iγ~2a~-C~γ2a~, Iγ~2b~-C~γ2b~, Iγ~3~-C~γ3~* and *I~α~-C~α~* GL transcription was evaluated by real-time PCR. (**C**) Bar graphs represent secreted IgM transcripts. Values were normalized to *GAPDH* transcripts. Mean ± SEM of two independent experiments with three mice and Mann--Whitney test for significance.](gkx203fig4){#F4}

We also explored *in vitro* whether the absence of the 3'RR palindromic shell lowered or delayed CSR. We quantified PST daily during a 5-day stimulation and found a decreased level of PST in *c3'RR* animals for *Cγ1, Cγ3, Cγ2a, Cγ2b* at all time points compared to *wt* mice. ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}).

Germline transcription (GLT) of a *C~H~* gene is a known prerequisite for CSR. We evaluated GLT in *in vitro* (LPS ± cytokines) activated splenic B cells from *wt, c3'RR* and *Δ3'RR* mice. All GLT were partially affected in *c3'RR* mice compared to *wt* and *3'RR* mice (Figure [4B](#F4){ref-type="fig"}). Altogether, these results indicated that a core-3'RR made up of naked core enhancers supported CSR at a significantly lower level than the full-length *wt* super-enhancer. Similar to *Δ3'RR* mice, where μ chain transcription is roughly normal in lymphocytes expressing membrane IgM but strongly declines (together with IgM secretion) in plasma cells, secreted-type μ transcripts (encoding secreted IgM) in *c3'RR* mice decreased to a level intermediate between *wt* and *Δ3'RR* mice (Figure [4C](#F4){ref-type="fig"}).

3'RR packaging DNA is mandatory for optimal SHM {#SEC3-4}
-----------------------------------------------

Using high throughput next generation sequencing, we explored SHM downstream of rearranged V(D)J genes in the *J~H~4* intron as described ([@B24]) (using the rearranged *Jκ5* intron as a control) in *wt, c3'RR* and *Δ3'RR* mice to determine the mechanistic impact of 3'RR alterations. Germinal center B-cells from Peyer\'s patches were sorted from *wt, c3'RR* and *Δ3'RR* mice and analyzed for SHM. In these settings, normal mutation frequencies in *wt* mice at the *IgH* (*J~H~4* and *Sμ* regions) and *Igk* loci were respectively 13.27‰, 7.7‰ and 11.8‰. As previously documented ([@B10]), *Δ3'RR* mice showed a strong SHM defect at the *IgH J~H~4* (1.48‰) and *Sμ* regions (2‰) (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}, [Supplementary Figure S4](#sup1){ref-type="supplementary-material"} for positions of mutations and ATGC tables). Strikingly, a similar SHM defect affected *IgH J~H~4* sequences obtained from *c3'RR* mice (1.48‰) indicating that the 3'RR stimulatory effect on *IgH* SHM needs not only core enhancers but also their palindromic packaging DNA. The same analysis was performed in the *Sμ* region, where we again observed a decreased SHM in *c3'RR* mice, at an intermediate level between *wt* and *Δ3'RR* mice (Figure [5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}).

![Core 3'RR enhancers do not optimally support SHM. (**A**) Somatic hypermutation at *J~H~4* intron (*left*), *Sμ* (*middle*) and *Jκ5* intron (*right*) of Peyer\'s patch GC B-cells sorted from *Δ3'RR, c3'RR* and *wt* mice. Data were obtained from two to three mice per group. T-test two-sided with Welch\'s correction for significance. (**B**) Number of mutations, bp analysed and mutation frequency at *J~H~4* intron, *Jκ5* intron and *Sμ* region for *Δ3'RR, c3'RR* and *wt* mice. Data represent a pool of at least two mice.](gkx203fig5){#F5}

DISCUSSION {#SEC4}
==========

The 3'RR is a strong super-enhancer regulating remodeling of the *IgH* locus in mature B cells and was even recently shown to have *trans*-acting effects on the other IgH allele ([@B1],[@B25]). Full deletion of the *3'RR* was previously reported to strongly impact CSR, SHM and the IgH boosted expression which ensures high antibody secretion by plasma cells ([@B6],[@B10]). By contrast, this deletion fully preserved early B-cell maturation and marginally impacted membrane IgM density and B-cell fate (toward slightly less marginal zone B-cells) ([@B6],[@B26]).

As any super-enhancer, the 3'RR integrates core enhancers buried in packaging DNA. Since transcription factors bind DNAse1 hypersensitive regions of core enhancers, and since large DNA fragments cannot easily be handled, many studies devoted to enhancer function and many transgenes supposedly providing 3'RR models simply omitted this packaging DNA ([@B15]--[@B19]).

More than 90% of mammalian DNA is non-coding and is often considered as useless ([@B27]), while this DNA might in fact play multiple roles, notably architectural. The 3'RR case is very specific due to its unique palindromic structure featuring several kb-long IRISs that flank the central *hs1,2* core enhancer ([@B12],[@B28]).

While alterations of the 3'RR made in the endogenous locus were initially shown to affect CSR ([@B7]), it was also observed that several precise deletions of a single core enhancer simply had no phenotype, provided the global structure of the 3'RR was maintained and no exogenous gene (such as a *neo* resistance cassette) was left inserted ([@B29]--[@B31]). By contrast, large deletions affecting multiple enhancers (and more recently a large deletion of the 5΄ half of the packaging palindromic DNA), while preserving core enhancers, all severely impacted class switching ([@B8],[@B14]). In agreement with these stereotyped CSR alterations following partial knock-outs, deletion of the entire 3'RR resulted in an almost complete CSR defect ([@B6]). Since miniaturized 3'RR substitutes, linking all four 3'RR core enhancers, have been widely used and considered to provide all 3'RR features, we wished, in the present study, to replace the full-length super-enhancer with its miniaturized (*c3'RR*) counterpart. We then evaluated this replacement in the physiologic context of the endogenous locus. Strikingly, this replacement severely affected CSR to some (IgG~3~, IgG~2a~, IgG~2b~...) but not all Ig classes (IgG~1~ was notably respected). This phenotype was strikingly similar to that of ΔIRIS mice lacking one half of the 3'RR repetitive packaging DNA ([@B14]). The *c3'RR* mice also poorly supported SHM and the level of mutation in the rearranged *J~H~4* intron was in fact similar to that in 3'RR-less B-cells ([@B32]). Again, this SHM phenotype was quite similar to that of *ΔIRIS* mice ([@B14]).

We finally observed decreased IgH expression in plasma cells indicated by decreased IgM plasma levels in mice and decreased amounts of secreted-type IgM transcripts, at a level intermediate between *wt* and *Δ3'RR* mice, which provided another similarity with the *ΔIRIS* mice ([@B6],[@B14]).

Altogether, our data indicate that the DNA shell surrounding core enhancers within the *IgH* 3'RR is not made up of useless junk DNA but, rather, contributes actively to 3'RR function. The ability of 3'RR core enhancers to support CSR and AID recruitment has been demonstrated by several previous studies in transgenes and transfectants and by deletion of the 3'RR *hs3b* and *hs4* core enhancers while respecting most of the 3'RR DNA shell ([@B8],[@B19]). The present study shows that while core enhancers are mandatory for full activity of the 3'RR super-enhancer, the surrounding sequences do not constitute useless junk DNA, but instrumentally contribute to 3'RR activity.

These observations clearly deserve to be considered for the future design of transgenic, knock-in or any other mouse engineered for Ig production (notably humanized) if efficient class switching and affinity maturation through SHM is desired.

Regarding the functional anatomy of the 3'RR super-enhancer and given the very strong similarity between the phenotype of *c3'RR* mice and that of *ΔIRIS* mice, our data suggest that the major activity of the 3'RR DNA shell is architectural and related to a necessary large DNA dyad symmetry of the regions flanking *hs1,2*. In that regard, deleting either flank of the palindrome in *ΔIRIS* or the whole palindromic DNA shell in *c3'RR* mice somehow yields a similar phenotype where core enhancers are working on their own and lacking the amplifying effect of the 3'RR 3D-architecture. Inverted repeats might function by positioning the *3'RR* in its optimal 3D-configuration, together with eRNA, lncRNA-CSR and transcription factors in order to stabilize a chromosomal organization that most efficiently recruits AID to mammalian *IgH* loci. Interestingly, we found no inverted repeats similar to those in the 3'RR around the mouse and human intronic *Eμ* or around *Eκ* and the *3'κ* enhancer. We found no palindrome either around the zebrafish *IgH* intronic and 3΄ regulatory elements ([@B33]). An attractive hypothesis is thus that the peculiar 3'IgH structure found in all mammals has been evolutionarily selected and contributes to the highly efficient class switching and somatic hypermutation that occurs in mammalian B cells.
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